Abstract Details
Mark Stahl, MD, PhD
(Insmed Gene Therapies)
PRESENTER |
Dr. Stahl has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Stahl has stock in Avidity Biosciences. |
No disclosure on file | |
No disclosure on file | |
Jeff M. Bronstein, MD, PhD (UCLA) | Dr. Bronstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ultragenyx. The institution of Dr. Bronstein has received research support from NIH. The institution of Dr. Bronstein has received research support from Levine Foundation. |
Daniel Hoch, MD, PhD, FAAN (Massachusetts General Hospital) | No disclosure on file |